NO20014364L - Ny cytokin-zalphall-ligand - Google Patents
Ny cytokin-zalphall-ligandInfo
- Publication number
- NO20014364L NO20014364L NO20014364A NO20014364A NO20014364L NO 20014364 L NO20014364 L NO 20014364L NO 20014364 A NO20014364 A NO 20014364A NO 20014364 A NO20014364 A NO 20014364A NO 20014364 L NO20014364 L NO 20014364L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- zalpha11 ligand
- new cytokine
- cytokine zalpha11
- seq
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26490899A | 1999-03-09 | 1999-03-09 | |
US26599299A | 1999-03-11 | 1999-03-11 | |
US14201399P | 1999-07-01 | 1999-07-01 | |
PCT/US2000/006067 WO2000053761A2 (en) | 1999-03-09 | 2000-03-09 | Human cytokine as ligand of the zalpha receptor and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20014364D0 NO20014364D0 (no) | 2001-09-07 |
NO20014364L true NO20014364L (no) | 2001-11-09 |
NO331551B1 NO331551B1 (no) | 2012-01-23 |
Family
ID=27385745
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014364A NO331551B1 (no) | 1999-03-09 | 2001-09-07 | Isolert cytokin-zalpha11-ligand-polypeptid, isolert polynukleotid, ekspresjonsvektor, dyrket celle, fremgangsmate for fremstilling av peptidet, antistoff som binder til peptidet, anvendelse av preparat omfattende peptidet for fremstilling av medikament for behandling av sykdom, fremgangsmate for pavisning av peptidet i en biologisk prove samt polypeptidet for anvendelse innen medisin |
NO20111085A NO20111085L (no) | 1999-03-09 | 2011-07-29 | Isolert cytokin-zalphall-ligand-polypeptid, isolert Polynukleotid, ekspresjonsvektor, dyrket celle, fremgangsmate for fremstilling av peptidet, antistoff som binder til peptidet, anvendelse av preparat omfattende peptidet for fremstilling av medikament for behandling av sykdom, fremgangsmate for pavisning av peptidet i en biologisk prove samt polypeptidet for anvendelse innen medisin |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20111085A NO20111085L (no) | 1999-03-09 | 2011-07-29 | Isolert cytokin-zalphall-ligand-polypeptid, isolert Polynukleotid, ekspresjonsvektor, dyrket celle, fremgangsmate for fremstilling av peptidet, antistoff som binder til peptidet, anvendelse av preparat omfattende peptidet for fremstilling av medikament for behandling av sykdom, fremgangsmate for pavisning av peptidet i en biologisk prove samt polypeptidet for anvendelse innen medisin |
Country Status (23)
Country | Link |
---|---|
EP (3) | EP1165791B1 (no) |
JP (1) | JP4405686B2 (no) |
KR (1) | KR100743640B1 (no) |
CN (5) | CN101575377B (no) |
AT (1) | ATE377076T1 (no) |
AU (2) | AU777842B2 (no) |
BR (1) | BR0008772B1 (no) |
CA (1) | CA2366921C (no) |
CZ (1) | CZ302921B6 (no) |
DE (1) | DE60036930T2 (no) |
DK (1) | DK1165791T3 (no) |
ES (1) | ES2295019T3 (no) |
HU (1) | HU229148B1 (no) |
IL (5) | IL145288A0 (no) |
MX (1) | MXPA01009074A (no) |
NO (2) | NO331551B1 (no) |
NZ (1) | NZ514708A (no) |
PL (1) | PL207350B1 (no) |
PT (1) | PT1165791E (no) |
RU (1) | RU2346951C2 (no) |
UA (1) | UA84387C2 (no) |
WO (1) | WO2000053761A2 (no) |
ZA (1) | ZA017370B (no) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7198789B2 (en) | 1998-03-17 | 2007-04-03 | Genetics Institute, Llc | Methods and compositions for modulating interleukin-21 receptor activity |
US6057128A (en) | 1998-03-17 | 2000-05-02 | Genetics Institute, Inc. | MU-1, member of the cytokine receptor family |
US7189400B2 (en) | 1998-03-17 | 2007-03-13 | Genetics Institute, Llc | Methods of treatment with antagonists of MU-1 |
WO2000053761A2 (en) * | 1999-03-09 | 2000-09-14 | Zymogenetics, Inc. | Human cytokine as ligand of the zalpha receptor and uses thereof |
EP1432431B1 (en) * | 2001-10-04 | 2017-05-10 | Genetics Institute LLC | Methods and compositions for modulating interleukin-21 activity |
AU2002336676A1 (en) | 2001-11-05 | 2003-05-19 | Zymogenetics, Inc | Il-21 antagonists |
JP2006514601A (ja) * | 2002-06-07 | 2006-05-11 | ザイモジェネティクス インコーポレイティッド | ガンおよびその他の治療用途におけるil−21の使用方法 |
CA2491320A1 (en) | 2002-07-15 | 2004-01-22 | Wyeth | Methods and compositions for modulating t helper (th) cell development and function |
EP1782823A3 (en) * | 2002-10-11 | 2007-05-16 | Novo Nordisk A/S | IL-21 peptides and nucleic acids |
CA2501807A1 (en) * | 2002-10-11 | 2004-04-22 | Novo Nordisk A/S | Treatment of allergic conditions by use of il 21 |
US7250274B2 (en) * | 2002-12-13 | 2007-07-31 | Zymogenetics, Inc. | IL-21 production in prokaryotic hosts |
NZ542306A (en) | 2003-03-14 | 2008-04-30 | Wyeth Corp | Antibodies against human IL-21 receptor and uses therefor |
CA2529520A1 (en) * | 2003-06-19 | 2004-12-29 | Centocor, Inc. | Interleukin-21 analogs |
DE602004031341D1 (de) | 2003-07-21 | 2011-03-24 | Transgene Sa | Multifunktionelle cytokine |
DK1648931T3 (da) | 2003-07-21 | 2011-03-07 | Transgene Sa | Multifunktionelle cytokiner |
AU2004275871A1 (en) * | 2003-09-25 | 2005-04-07 | Zymogenetics, Inc. | Methods of treating autoimmune diseases using IL-21 |
US20060228331A1 (en) * | 2003-10-10 | 2006-10-12 | Novo Nordisk A/S | IL-21 Derivatives and variants |
CN1867581B (zh) * | 2003-10-10 | 2012-02-01 | 诺沃挪第克公司 | Il-21衍生物 |
ES2428358T3 (es) | 2003-10-17 | 2013-11-07 | Novo Nordisk A/S | Terapia de combinación |
EP1708737A2 (en) * | 2004-01-15 | 2006-10-11 | Novo Nordisk A/S | Use of interleukin-21 for the treatment of autoimmune diseases and allograft rejection |
DK2842576T3 (en) | 2004-01-21 | 2017-10-16 | Novo Nordisk Healthcare Ag | Transglutaminase-mediated peptide conjugation |
GT200600148A (es) | 2005-04-14 | 2006-11-22 | Metodos para el tratamiento y la prevencion de fibrosis | |
BRPI0609079A2 (pt) | 2005-04-18 | 2010-11-16 | Novo Nordisk As | peptìdeo, composição farmacêutica, método para o tratamento de cáncer, uso de um peptìdeo construto de ácido nucleico, vetor, hospedeiro, e, anticorpo |
JP5322653B2 (ja) | 2005-11-28 | 2013-10-23 | ザイモジェネティクス, インコーポレイテッド | Il−21アンタゴニスト |
EP2091968A2 (en) | 2006-10-26 | 2009-08-26 | Novo Nordisk A/S | Il-21 variants |
CA2671665A1 (en) | 2006-12-21 | 2008-06-26 | Novo-Nordisk A/S | Interleukin-21 variants with altered binding to the il-21 receptor |
CN102027011B (zh) | 2007-12-07 | 2014-09-03 | 津莫吉尼蒂克斯公司 | 抗人il-21单克隆抗体 |
AR071885A1 (es) | 2008-05-23 | 2010-07-21 | Wyeth Corp | Proteinas de union al receptor de interleuquina 21 |
RU2010152689A (ru) | 2008-05-23 | 2012-06-27 | УАЙТ ЭлЭлСи (US) | Способы лечения с применением белков, связывающих рецептор интерлейкина-21 |
EP2344180A2 (en) | 2008-09-23 | 2011-07-20 | Wyeth LLC | Methods for predicting production of activating signals by cross-linked binding proteins |
CN102021196B (zh) * | 2009-11-20 | 2013-06-26 | 上海杰隆生物工程股份有限公司 | 毕赤酵母生产重组人白细胞介素21的方法 |
IN2015KN00073A (no) | 2012-06-27 | 2015-07-31 | Univ Rutgers | |
WO2015110930A1 (en) | 2014-01-24 | 2015-07-30 | Pfizer Inc. | Modified interleukin 21 receptor proteins |
EP2982693A1 (en) * | 2014-08-07 | 2016-02-10 | Affimed Therapeutics AG | CD3 binding domain |
US12012441B2 (en) | 2020-10-26 | 2024-06-18 | Neptune Biosciences Llc | Engineered human IL-21 cytokines and methods for using the same |
CN112662694A (zh) * | 2020-12-25 | 2021-04-16 | 康九生物科技(长春)有限公司 | 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU560472B2 (en) | 1981-08-25 | 1987-04-09 | Celltech Limited | Yeast expression vectors |
US4579821A (en) | 1981-11-23 | 1986-04-01 | University Patents, Inc. | Control of DNA sequence transcription |
US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
US4486533A (en) | 1982-09-02 | 1984-12-04 | St. Louis University | Filamentous fungi functional replicating extrachromosomal element |
US4599311A (en) | 1982-08-13 | 1986-07-08 | Kawasaki Glenn H | Glycolytic promotersfor regulated protein expression: protease inhibitor |
US4977092A (en) | 1985-06-26 | 1990-12-11 | Amgen | Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
US4661454A (en) | 1983-02-28 | 1987-04-28 | Collaborative Research, Inc. | GAL1 yeast promoter linked to non galactokinase gene |
US5139936A (en) | 1983-02-28 | 1992-08-18 | Collaborative Research, Inc. | Use of the GAL1 yeast promoter |
US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
US4870008A (en) | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
US4931373A (en) | 1984-05-25 | 1990-06-05 | Zymogenetics, Inc. | Stable DNA constructs for expression of α-1 antitrypsin |
US4766073A (en) | 1985-02-25 | 1988-08-23 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
EP0184576B1 (en) | 1984-12-06 | 1990-06-27 | Fina Research S.A. | Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
US4882279A (en) | 1985-10-25 | 1989-11-21 | Phillips Petroleum Company | Site selective genomic modification of yeast of the genus pichia |
US4935349A (en) | 1986-01-17 | 1990-06-19 | Zymogenetics, Inc. | Expression of higher eucaryotic genes in aspergillus |
GB8611832D0 (en) | 1986-05-15 | 1986-06-25 | Holland I B | Polypeptide |
US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
US5063154A (en) | 1987-06-24 | 1991-11-05 | Whitehead Institute For Biomedical Research | Pheromone - inducible yeast promoter |
US5567584A (en) | 1988-01-22 | 1996-10-22 | Zymogenetics, Inc. | Methods of using biologically active dimerized polypeptide fusions to detect PDGF |
ATE140963T1 (de) | 1988-01-22 | 1996-08-15 | Zymogenetics Inc | Verfahren zur herstellung von sekretierten rezeptoranalogen |
US4956288A (en) | 1988-04-22 | 1990-09-11 | Biogen, Inc. | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA |
US5037743A (en) | 1988-08-05 | 1991-08-06 | Zymogenetics, Inc. | BAR1 secretion signal |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5162228A (en) | 1988-12-28 | 1992-11-10 | Takeda Chemical Industries, Ltd. | Gylceraldehyde-3-phosphate dehydrogenase gene and promoter |
US5124263A (en) | 1989-01-12 | 1992-06-23 | Wisconsin Alumni Research Foundation | Recombination resistant retroviral helper cell and products produced thereby |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5162222A (en) | 1989-07-07 | 1992-11-10 | Guarino Linda A | Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses |
IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
US5298418A (en) | 1991-09-16 | 1994-03-29 | Boyce Thompson Institute For Plant Research, Inc. | Cell line isolated from larval midgut tissue of Trichoplusia ni |
US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
CA2144651A1 (en) | 1992-09-14 | 1994-03-31 | Timothy J. Miller | Immortalized cells and uses therefor |
WO1995007358A1 (en) | 1993-07-30 | 1995-03-16 | University Of Medicine & Dentistry Of New Jersey | Efficient gene transfer into primary lymphocytes |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5795966A (en) * | 1995-02-22 | 1998-08-18 | Immunex Corp | Antagonists of interleukin-15 |
CA2237120C (en) | 1995-11-09 | 2005-03-01 | Zymogenetics, Inc. | Compositions and methods for producing heterologous polypeptides in pichia methanolica |
AU718510B2 (en) | 1996-07-17 | 2000-04-13 | Zymogenetics Inc. | Transformation of pichia methanolica |
CN1238806A (zh) | 1996-07-17 | 1999-12-15 | 津莫吉尼蒂克斯公司 | 甲醇毕赤酵母营养突变体的制备 |
KR20080059467A (ko) | 1996-12-03 | 2008-06-27 | 아브게닉스, 인크. | 복수의 vh 및 vk 부위를 함유하는 사람 면역글로불린유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된항체 |
IL122818A0 (en) * | 1997-07-10 | 1998-08-16 | Yeda Res & Dev | Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof |
US6057128A (en) * | 1998-03-17 | 2000-05-02 | Genetics Institute, Inc. | MU-1, member of the cytokine receptor family |
WO2000053761A2 (en) * | 1999-03-09 | 2000-09-14 | Zymogenetics, Inc. | Human cytokine as ligand of the zalpha receptor and uses thereof |
US9418201B1 (en) | 2015-11-19 | 2016-08-16 | International Business Machines Corporation | Integration of functional analysis and common path pessimism removal in static timing analysis |
-
2000
- 2000-03-09 WO PCT/US2000/006067 patent/WO2000053761A2/en active Application Filing
- 2000-03-09 CN CN2009101354816A patent/CN101575377B/zh not_active Expired - Fee Related
- 2000-03-09 IL IL14528800A patent/IL145288A0/xx unknown
- 2000-03-09 CN CN2011103037822A patent/CN102406937A/zh active Pending
- 2000-03-09 PT PT00916164T patent/PT1165791E/pt unknown
- 2000-03-09 DE DE60036930T patent/DE60036930T2/de not_active Expired - Lifetime
- 2000-03-09 AU AU37312/00A patent/AU777842B2/en not_active Ceased
- 2000-03-09 CN CNA2005101141968A patent/CN1827639A/zh active Pending
- 2000-03-09 NZ NZ514708A patent/NZ514708A/en not_active IP Right Cessation
- 2000-03-09 HU HU0200418A patent/HU229148B1/hu not_active IP Right Cessation
- 2000-03-09 CZ CZ20013184A patent/CZ302921B6/cs not_active IP Right Cessation
- 2000-03-09 CA CA2366921A patent/CA2366921C/en not_active Expired - Fee Related
- 2000-03-09 JP JP2000603382A patent/JP4405686B2/ja not_active Expired - Fee Related
- 2000-03-09 EP EP00916164A patent/EP1165791B1/en not_active Expired - Lifetime
- 2000-03-09 UA UA2001106769A patent/UA84387C2/ru unknown
- 2000-03-09 BR BRPI0008772-6A patent/BR0008772B1/pt not_active IP Right Cessation
- 2000-03-09 DK DK00916164T patent/DK1165791T3/da active
- 2000-03-09 ES ES00916164T patent/ES2295019T3/es not_active Expired - Lifetime
- 2000-03-09 RU RU2004126135/13A patent/RU2346951C2/ru not_active IP Right Cessation
- 2000-03-09 CN CNB008068747A patent/CN100500846C/zh not_active Expired - Fee Related
- 2000-03-09 KR KR1020017011499A patent/KR100743640B1/ko not_active IP Right Cessation
- 2000-03-09 CN CN2006101031515A patent/CN1927883B/zh not_active Expired - Fee Related
- 2000-03-09 MX MXPA01009074A patent/MXPA01009074A/es active IP Right Grant
- 2000-03-09 EP EP20100185147 patent/EP2295577A3/en not_active Withdrawn
- 2000-03-09 PL PL351160A patent/PL207350B1/pl unknown
- 2000-03-09 EP EP07017344A patent/EP1881070B1/en not_active Expired - Lifetime
- 2000-03-09 AT AT00916164T patent/ATE377076T1/de active
-
2001
- 2001-09-05 IL IL145288A patent/IL145288A/en not_active IP Right Cessation
- 2001-09-06 ZA ZA2001/07370A patent/ZA017370B/en unknown
- 2001-09-07 NO NO20014364A patent/NO331551B1/no not_active IP Right Cessation
-
2005
- 2005-01-20 AU AU2005200240A patent/AU2005200240A1/en not_active Abandoned
-
2008
- 2008-12-04 IL IL195713A patent/IL195713A/en not_active IP Right Cessation
-
2010
- 2010-08-04 IL IL207403A patent/IL207403A/en not_active IP Right Cessation
- 2010-08-05 IL IL207424A patent/IL207424A/en not_active IP Right Cessation
-
2011
- 2011-07-29 NO NO20111085A patent/NO20111085L/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20014364D0 (no) | Ny cytokin-zalphall-ligand | |
NO20043419L (no) | Nytt cytokin, zcytor17-ligand | |
TR199501182A2 (tr) | Pestisid özellikte yeni proteinler ve suslar. | |
EP1591529A3 (en) | Human CLTA-8 and uses of CTLA-8-related proteins | |
DK1114156T3 (da) | Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr | |
EP0967283A4 (en) | GENES CODING FOR PROTEINS WITH TRANSGLYCOLYSTING ACTIVITY. | |
AU2002307510A1 (en) | Cytokine protein family | |
DE69931807D1 (de) | Herstellung von ascorbinsäure unter verwendung von hefe | |
IL142709A0 (en) | Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof | |
DK1001929T3 (da) | Fremgangsmåde til fremstilling af 3-cyano-2,4-dihalogen-5-flour-benzoesyrer | |
DE69637429D1 (de) | Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert | |
EA200100440A1 (ru) | Ген prv-1 и его применение | |
EA200200286A1 (ru) | Ген prv-1 и его применение | |
ES2093596T2 (es) | Colesterol oxidasa nueva. | |
EP1295943A4 (en) | POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES | |
DK0382268T3 (da) | Aminocarboxylsyrederivater | |
NZ606260A (en) | Novel polypeptides involved in immune response | |
DE69632205T2 (de) | Herstellung von bacillus thuringiensis integrants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |